64 Mile Overnight walk for CBAG King's College Hosp to Hove

Charlotte’s BAG stands out as one of the few charities in the UK dedicated to funding research into glioblastoma multiforme and raising awareness about this rare, and almost always fatal, brain cancer that can strike at any age. Adolescents are particularly vulnerable due to the significant brain development occurring during these years, complicating treatment efforts for glioblastoma.

Since the introduction of temozolomide in 1990, there have been no major advances in brain cancer treatment. The lack of funding is stark, with brain cancer research receiving approximately only 1% of the annual cancer research budget. This underfunding is a key factor behind the minimal progress made in brain cancer treatment, in contrast to other cancers which have benefited from substantial investments and seen significant improvements in survival rates.

Charlotte Eades, who passed away from glioblastoma just one week after her 19th birthday in February 2016, left a lasting impact on many young people facing cancer.

The name Charlotte’s BAG, standing for Battle Against Glioblastoma, also pays tribute to Charlotte’s love for handbags. Our commitment to self-funding ensures that every single penny donated is directed towards research efforts.

Where your money will go:

Charlotte's Lab is a research facility set up in Charlotte's name at King's College Hospital, London. The Charlotte’s BAG Team at King’s College Hospital are evaluating different approaches for mutation detection. This will be useful for monitoring patients after a diagnosis has been made. The Team are investigating a highly sensitive means of mutation detection which, it is hoped, will permit the detection of one molecule in 10,000-100,000. Such a means of detection enables oncologists to understand if surgery or therapy has been effective. The Team are using the research to assess further whether it is possible to classify tumours from cerebrospinal fluid without removing tumour tissue. As a member of the Team stated, though very early days, ‘this technology could be the future of brain tumour diagnostics.’

The teams at King's always make a presentation to the charity before any money is deposited with them.